Haemonetics Corporation (HAE) Balance Sheet

As of 2026-06-27 (10-Q), Haemonetics Corporation (HAE) reported total assets of $2.4B and shareholders' equity of $837.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $223.4M. Long-term debt: $1.2B.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HAEHaemonetics CorporationFollow HAE — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 5.4B
P/E TTM: 57.3
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Line	FY2011 Apr 11	FY2012 Mar 12	FY2013 Mar 13	FY2014 Mar 14	FY2015 Mar 15	FY2016 Apr 16	FY2017 Apr 17	FY2018 Mar 18	FY2019 Mar 19	FY2020 Mar 20	FY2021 Apr 21	FY2022 Apr 22	FY2023 Apr 23	FY2024 Mar 24	FY2025 Mar 25	FY2026 Mar 26	Latest Jun 26
Cash and equivalents	0.20	0.23	0.18	0.19	0.16	0.12	0.14	0.18	0.17	0.14	0.19	0.26	0.28	0.18	0.31	0.25	0.22
Receivables	0.13	0.14	0.17	0.16	0.15	0.16	0.15	0.15	0.19	0.17	0.13	0.16	0.18	0.21	0.20	0.22	0.22
Inventory	0.08	0.12	0.18	0.20	0.21	0.19	0.18	0.16	0.19	0.27	0.32	0.29	0.26	0.32	0.37	0.31	0.31
Current assets	0.45	0.53	0.60	0.62	0.56	0.49	0.51	0.52	0.58	0.60	0.69	0.76	0.77	0.77	0.93	0.83	0.81
Total assets	0.83	0.91	1.46	1.51	1.49	1.32	1.24	1.24	1.27	1.27	1.82	1.86	1.93	2.20	2.45	2.40	2.37
Current liabilities	0.11	0.13	0.18	0.22	0.19	0.19	0.21	0.38	0.24	0.27	0.25	0.44	0.25	0.30	0.58	0.28	0.26
Long-term debt	0.00	0.00	0.46	0.39	0.41	0.36	0.25	0.06	0.32	0.31	0.69	0.56	0.75	0.80	0.92	1.22	1.17
Short-term debt	0.00	0.00	0.02	0.05	0.02	0.04	0.06	0.19	0.03	0.08	0.02	0.21	0.01	0.01	0.30	0.01	0.00
Shareholders' equity	0.69	0.73	0.77	0.84	0.83	0.72	0.74	0.75	0.67	0.59	0.73	0.75	0.82	0.96	0.82	0.80	0.84

USD billions · SEC XBRL

Haemonetics Corporation — questions

How much cash does Haemonetics Corporation have?: $223.4M in cash and cash equivalents as of 2026-06-27.
How much debt does Haemonetics Corporation have?: $1.2B of long-term debt and $5.0M due within a year as of 2026-06-27.
What are Haemonetics Corporation's total assets?: $2.4B as of 2026-06-27.
What is Haemonetics Corporation's shareholders' equity?: $837.1M as of 2026-06-27.

Every figure on this page comes from Haemonetics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.